KHN702

· Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KHN702, covering 2025-07-01 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects [Phase 1]